Association between serum ALT levels and incidence of new-onset diabetes in general population of Japanese: a longitudinal observational study (ISSA-CKD).
general diabetes
retrospective studies
risk factors
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
07 08 2023
07 08 2023
Historique:
medline:
9
8
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
We aimed to clarify the relationship between serum alanine transaminase (ALT) levels and incidence of new-onset diabetes in a Japanese general population. Population-based retrospective cohort study using annual health check-up data for residents of Iki City, Nagasaki Prefecture, Japan. A total of 5330 Japanese individuals (≥30 years old) without diabetes at baseline were analysed. Serum ALT levels were determined using an enzymatic method and were classified into gender-specific quartile groups as follows: group 1 (3-16 U/L in men and 3-13 U/L in women), group 2 (17-21 U/L in men and 14-16 U/L in women), group 3 (22-29 U/L in men and 17-22 U/L in women) and group 4 (30-428 U/L in men and 23-268 U/L in women). The study outcome was the incidence of diabetes (fasting glucose ≥7.0 mmol/L, non-fasting glucose ≥11.1 mmol/L, glycated haemoglobin ≥6.5% or use of glucose-lowering therapies). After an average follow-up period of 5.0 years, 279 individuals developed diabetes. The incidence rate of diabetes increased with elevation of serum ALT levels (0.7% per 100 person-years in group 1, 0.9% in group 2, 0.9% in group 3 and 1.7% in group 4) (p<0.001 for trend). This association was significant after adjustment for other risk factors including age, sex, obesity, hypertension, dyslipidaemia, smoking, current daily alcohol intake and regular exercise (p<0.001 for trend). Comparable associations were observed between men and women (p=0.459 for interaction). Serum ALT levels were associated with future development of diabetes in the general Japanese population.
Identifiants
pubmed: 37550028
pii: bmjopen-2023-074007
doi: 10.1136/bmjopen-2023-074007
pmc: PMC10407361
doi:
Substances chimiques
Alanine Transaminase
EC 2.6.1.2
Glucose
IY9XDZ35W2
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e074007Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Diabetes Care. 2011 Dec;34(12):2603-7
pubmed: 21953798
J Epidemiol. 2017 Dec;27(12):553-561
pubmed: 28716381
Diabetologia. 2016 Dec;59(12):2527-2545
pubmed: 27747395
J Virol. 2008 Mar;82(6):2606-12
pubmed: 18160431
Diabetol Metab Syndr. 2014 Feb 06;6(1):14
pubmed: 24502834
J Clin Med. 2021 May 01;10(9):
pubmed: 34062802
J Hum Hypertens. 2019 Dec;33(12):873-878
pubmed: 31113986
Tohoku J Exp Med. 2020;251(3):183-191
pubmed: 32669486
PLoS One. 2021 Feb 2;16(2):e0246304
pubmed: 33529192
Sci Transl Med. 2013 Jan 30;5(170):170ra14
pubmed: 23363978
Lancet Diabetes Endocrinol. 2015 Dec;3(12):958-67
pubmed: 26388413
Diabetes Care. 2009 Nov;32(11):2123-32
pubmed: 19875607
Lancet Diabetes Endocrinol. 2014 Jun;2(6):474-80
pubmed: 24731674
Diabetes Res Clin Pract. 2020 Feb;160:108002
pubmed: 31904446
Intern Med. 2020 Jan 15;59(2):175-180
pubmed: 31554753
J Epidemiol. 2016;26(4):224-32
pubmed: 26725285
Diabet Med. 2021 Aug;38(8):e14522
pubmed: 33434318
J Diabetes Res. 2020 Aug 24;2020:1032049
pubmed: 32908932
Int J Mol Sci. 2020 Oct 31;21(21):
pubmed: 33142938
Nutrients. 2017 Apr 14;9(4):
pubmed: 28420094
Ann Hepatol. 2019 Mar - Apr;18(2):298-303
pubmed: 31040092
Diabetes Res Clin Pract. 2015 Mar;107(3):320-31
pubmed: 25638454
Ann Transl Med. 2021 Feb;9(4):326
pubmed: 33708953
Hepatology. 2019 Aug;70(2):711-724
pubmed: 30556145
Nutr Metab (Lond). 2019 Sep 13;16:64
pubmed: 31528183
J Clin Hypertens (Greenwich). 2021 Dec;23(12):2071-2077
pubmed: 34806282
Sci Rep. 2017 Jul 5;7(1):4649
pubmed: 28680048
Obesity (Silver Spring). 2007 Jul;15(7):1841-50
pubmed: 17636103
Diabetes Care. 2008 Oct;31(10):1949-54
pubmed: 18591401
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S1-S7
pubmed: 29511464
Circ J. 2002 Nov;66(11):987-92
pubmed: 12419927
Arch Intern Med. 2011 Aug 8;171(15):1352-60
pubmed: 21824948
Public Health Nutr. 2015 Nov;18(16):3013-9
pubmed: 25686619
J Diabetes Investig. 2019 May;10(3):837-845
pubmed: 30204299
Metabolism. 2017 Jul;72:94-108
pubmed: 28641788